This clinical trial, sponsored by Endo Pharmaceuticals, evaluated the effectiveness and safety of Lidoderm as an add-on treatment for patients experiencing postherpetic neuralgia, diabetic neuropathy, or low back pain while on a gabapentin regimen. The study involved 107 participants and was conducted across multiple sites in the United States.